PanCanSeek®
Hematologic Malignancies Precision Diagnosis and Therapeutics Guidance Test
PanCanSeek® utilizes whole-genome sequencing (50×) of bone marrow cell DNA to offer comprehensive genomic profiling. By capturing four types of genomic variants, including structural variants (SVs), copy number aberrations (CNAs), copy number neutral loss of heterozygosity (CN-LOH), and single nucleotide variations (SNVs and InDels), this approach enables clinicians to conduct accurate molecular typing, effective prognostic stratification, and precise therapeutic guidance.
One for All
PanCanSeek®, one test to detect four types of genetic variations across the entire genome.
How it works
Order
Consult your doctor to order through a local healthcare partner
Blood draw
2 mL of bone marrow is collected and delivered to the central lab
Testing
Detection is performed using next generation sequencing (NGS) platform
Reporting
Results are ready within 15 working days after the sample arrives at the central lab
